Lynch & Associates Merck & Co., Inc. Transaction History

Lynch & Associates

  • $467 Million
  • Q3 2024

A detailed history of Lynch & Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lynch & Associates holds 92,701 shares of MRK stock, worth $9.09 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
92,701
Previous 92,926 0.24%
Holding current value
$9.09 Million
Previous $11.5 Million 8.49%
% of portfolio
2.25%
Previous 2.62%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$111.15 - $128.97 $25,008 - $29,018
-225 Reduced 0.24%
92,701 $10.5 Million
Q2 2024

Aug 06, 2024
BUY
$123.8 - $132.96 $339,335 - $364,443
2,741 Added 3.04%
92,926 $11.5 Million
Q1 2024

Apr 09, 2024
SELL
$113.24 - $131.95 $501,766 - $584,670
-4,431 Reduced 4.68%
90,185 $11.9 Million
Q4 2023

Jan 08, 2024
SELL
$100.18 - $109.02 $169,504 - $184,461
-1,692 Reduced 1.76%
94,616 $10.3 Million
Q3 2023

Oct 24, 2023
SELL
$102.95 - $114.33 $327,381 - $363,569
-3,180 Reduced 3.2%
96,308 $9.91 Million
Q2 2023

Oct 24, 2023
SELL
$108.61 - $118.38 $36,492 - $39,775
-336 Reduced 0.34%
99,488 $11.5 Million
Q2 2023

Jul 13, 2023
SELL
$108.61 - $118.38 $36,492 - $39,775
-336 Reduced 0.34%
99,488 $11.5 Million
Q1 2023

Oct 24, 2023
BUY
$102.94 - $114.86 $34,587 - $38,592
336 Added 0.34%
99,824 $10.6 Million
Q1 2023

Apr 04, 2023
SELL
$102.94 - $114.86 $155,645 - $173,668
-1,512 Reduced 1.49%
99,824 $10.6 Million
Q4 2022

Oct 24, 2023
BUY
$87.44 - $112.11 $439,648 - $563,689
5,028 Added 5.22%
101,336 $11.2 Million
Q4 2022

Jan 05, 2023
SELL
$87.44 - $112.11 $316,270 - $405,501
-3,617 Reduced 3.45%
101,336 $11.2 Million
Q3 2022

Oct 03, 2022
BUY
$84.53 - $94.96 $55,282 - $62,103
654 Added 0.63%
104,953 $9.04 Million
Q2 2022

Jul 06, 2022
SELL
$83.49 - $94.64 $78,063 - $88,488
-935 Reduced 0.89%
104,299 $9.51 Million
Q1 2022

Apr 08, 2022
BUY
$73.51 - $82.4 $12,055 - $13,513
164 Added 0.16%
105,234 $8.63 Million
Q4 2021

Jan 11, 2022
BUY
$72.28 - $90.54 $206,865 - $259,125
2,862 Added 2.8%
105,070 $8.05 Million
Q3 2021

Oct 12, 2021
BUY
$71.68 - $78.83 $177,264 - $194,946
2,473 Added 2.48%
102,208 $7.68 Million
Q2 2021

Jul 21, 2021
SELL
$70.31 - $77.77 $83,247 - $92,079
-1,184 Reduced 1.17%
99,735 $7.76 Million
Q1 2021

Apr 09, 2021
SELL
$68.86 - $81.11 $157,551 - $185,579
-2,288 Reduced 2.22%
100,919 $7.78 Million
Q4 2020

Jan 20, 2021
BUY
$71.77 - $79.65 $62,942 - $69,853
877 Added 0.86%
103,207 $8.44 Million
Q3 2020

Oct 21, 2020
SELL
$73.18 - $82.95 $33,150 - $37,576
-453 Reduced 0.44%
102,330 $8.49 Million
Q2 2020

Jul 20, 2020
SELL
$70.42 - $80.13 $148,867 - $169,394
-2,114 Reduced 2.02%
102,783 $7.95 Million
Q1 2020

Apr 28, 2020
SELL
$63.36 - $87.82 $506 - $702
-8 Reduced 0.01%
104,897 $8.07 Million
Q4 2019

Jan 10, 2020
BUY
$77.58 - $87.54 $398,373 - $449,517
5,135 Added 5.15%
104,905 $9.54 Million
Q3 2019

Oct 03, 2019
BUY
$76.08 - $82.93 $48,386 - $52,743
636 Added 0.64%
99,770 $8.4 Million
Q2 2019

Jul 19, 2019
SELL
$69.84 - $81.59 $80,455 - $93,991
-1,152 Reduced 1.15%
99,134 $8.31 Million
Q1 2019

Apr 25, 2019
BUY
$69.58 - $79.36 $88,853 - $101,342
1,277 Added 1.29%
100,286 $8.34 Million
Q4 2018

Jan 10, 2019
BUY
$65.24 - $75.71 $22,703 - $26,347
348 Added 0.35%
99,009 $7.57 Million
Q3 2018

Oct 05, 2018
SELL
$57.69 - $67.84 $114,687 - $134,865
-1,988 Reduced 1.98%
98,661 $7 Million
Q2 2018

Jul 09, 2018
BUY
$50.83 - $59.72 $412,637 - $484,806
8,118 Added 8.77%
100,649 $6.11 Million
Q1 2018

Apr 06, 2018
SELL
$50.96 - $59.23 $5,452 - $6,337
-107 Reduced 0.12%
92,531 $5.04 Million
Q4 2017

Jan 04, 2018
SELL
$51.62 - $61.64 $211,538 - $252,600
-4,098 Reduced 4.24%
92,638 $5.21 Million
Q3 2017

Oct 18, 2017
BUY
$58.67 - $63.13 $5.68 Million - $6.11 Million
96,736
96,736 $6.19 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email